Xanthohumol inhibits non‐small cell lung cancer via directly targeting T‐lymphokine‐activated killer cell‐originated protein kinase
- 7 March 2023
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 37 (7) , 3057-3068
Abstract
Xanthohumol is a principal prenylated chalcone isolated from hops. Previous studies have shown that xanthohumol was effective against various types of cancer, but the mechanisms, especially the direct targets for xanthohumol to exert an anticancer effect, remain elusive. Overexpression of T‐lymphokine‐activated killer cell‐originated protein kinase (TOPK) promotes tumorigenesis, invasion and metastasis, implying the likely potential for targeting TOPK in cancer prevention and treatment. In the present study, we found that xanthohumol significantly inhibited the cell proliferation, migration and invasion of non‐small cell lung cancer (NSCLC) in vitro and suppressed tumor growth in vivo, which is well correlated with inactivating TOPK, evidenced by reduced phosphorylation of TOPK and its downstream signaling histone H3 and Akt, and decreased its kinase activity. Moreover, molecular docking and biomolecular interaction analysis showed that xanthohumol was able to directly bind to the TOPK protein, suggesting that TOPK inactivation by xanthohumol is attributed to its ability to directly interact with TOPK. The findings of the present study identified TOPK as a direct target for xanthohumol to exert its anticancer activity, revealing novel insight into the mechanisms underlying the anticancer activity of xanthohumol.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFC1603706)
This publication has 42 references indexed in Scilit:
- PBK/TOPK expression in non‐small‐cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expressionHistopathology, 2013
- Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer GrowthCancer Research, 2012
- Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB–regulated gene products and potentiation of apoptosis in leukemia cellsBlood, 2009
- Bidirectional Signals Transduced by TOPK-ERK Interaction Increase Tumorigenesis of HCT116 Colorectal Cancer CellsGastroenterology, 2007
- Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein–protein interaction with tumor suppressor p53Biochemical and Biophysical Research Communications, 2007
- T-Lymphokine–Activated Killer Cell–Originated Protein Kinase Functions as a Positive Regulator of c-Jun-NH2-Kinase 1 Signaling and H-Ras–Induced Cell TransformationCancer Research, 2007
- PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage responseOncogene, 2006
- PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast CancerCancer Research, 2006
- PBK/TOPK Is a Novel Mitotic Kinase Which Is Upregulated in Burkitt's Lymphoma and Other Highly Proliferative Malignant CellsBlood Cells, Molecules, and Diseases, 2001
- Cloning and Expression of a Novel MAPKK-like Protein Kinase, Lymphokine-activated Killer T-cell-originated Protein Kinase, Specifically Expressed in the Testis and Activated Lymphoid CellsJournal of Biological Chemistry, 2000